Motivación y conocimiento de la solicitud y significado de los resultados del cribado de drogas de abuso en orina
- Bartomeu Castanyer Puig
- Bernardí Barceló Martín
- Josep M. Queraltó Compañó
- Rosa Díaz García
- Carmen Farré Masip
- Elena Llorente Fernández
- Ana Argudo Ramírez
ISSN: 1888-4008
Ano de publicación: 2012
Volume: 5
Número: 4
Páxinas: 165-169
Tipo: Artigo
Outras publicacións en: Revista del laboratorio clínico
Obxectivos de Desenvolvemento Sustentable
Resumo
Objectives: To demonstrate whether the primary reason for requesting the laboratory determinations of drugs of abuse in urine (DAU) for immunoassay is to confirm or exclude a diagnostic impression, and to determine the level of knowledge on the significance of the cut-off value. Material and methods: We designed a survey that consisted of four questions, two referring to the reasons for the request of the DAU immunoassay and two to the significance of the cut-off. The data was collected during May and June 2010, and the only requirement of the respondents was that they worked in a hospital emergency department. Results: Of 244 questionnaires received, 199 were considered valid. A large majority (82.9%) of respondents made the request for DAU screening always or almost always to confirm a diagnostic impression, and 17.0% never or rarely used it for this purpose. Drug abuse screening was always or almost always requested by 68.3% to rule out a diagnostic impression, and31.6% rarely or never used them for this purpose. The significance of a positive result was understood by 51.2%, and 49.7% understood a negative result. Conclusions: Ordering DAU tests requires specific knowledge of the reason as well as to interpret the result. Clinical laboratories should be involved in training the requesters on the significance of DAU screening.